Excitatory transmission in the CNS necessitates the existence of dynamic controls of the glutamate uptake achieved by astrocytes, both in physiological conditions and under pathological circumstances characterized by gliosis. In this context, this study was aimed at evaluating the involvement of group I metabotropic glutamate receptors (mGluR) in the regulation of glutamate transport in a model of rat astrocytes undergoing in vitro activation using a cocktail of growth factors (G5 supplement). The vast majority of the cells were found to take up aspartate, mainly through the glutamate/aspartate transporter (GLAST), and at least 60% expressed functional mGluR5a. When exposed for 15 s to the selective group I mGluR agonist (S)-3,5-dihydroxyphenylglycine, reactive astrocytes showed a significant increase in their capacity to take up aspartate. This effect was confirmed at the single-cell level, since activation of mGluRs significantly increased the initial slope of aspartate-dependent Na + entry associated with the activity of glutamate transporters. This up-regulation was inhibited by an antagonist of mGluR5 and, more importantly, was sensitive to a specific glutamate transporter 1 (GLT-1) blocker. The acute influence of mGluR5 on aspartate uptake was phospholipase C-and protein kinase C-dependent, and was mimicked by phorbol esters. We conclude that mGluR5a contributes to a dynamic control of GLT-1 function in activated astrocytes, acting as a glial sensor of the extracellular glutamate concentration in order to acutely regulate the excitatory transmission. Efficient glutamate clearance at the vicinity of responding neurones is a key feature of the physiological excitatory transmission in the CNS of mammals. This process involves high-affinity specific transporters present on both neuronal and glial membranes. In particular, the glial glutamate transporters GLAST (glutamate/aspartate transporter) and GLT-1 (glutamate transporter 1) prevent abnormal rises of extracellular synaptic glutamate concentrations to excitotoxic levels, which cause excessive stimulation of glutamate receptors, oxidative stress and neuronal damage. Many studies have revealed that the expression and activity of glutamate transporters are largely influenced by the environment (Drejer et al. 1983;Gegelashvili et al. 1997; Swanson et al. 1997), in particular by growth factors and cytokines. Indeed, regulation of glutamate transporters in the CNS has been documented during animal development. In addition, increased brain levels of several growth factors are observed in pathological circumstances involving gliosis, in which activated astrocytes are suggested to enhance local neuroprotection (Liberto et al. 2004 Abbreviations used: bFGF, basic fibroblast growth factor; bp, base pair; CPCCOEt, 7-hydroxyiminocyclopropan [b]chromen-1a-carboxylic acid ethyl ester; CY3, cyanin 3; DHK, dihydrokainic acid; DHPG, (S)-3,5-dihydroxyphenylglycine; EGF, epidermal growth factor; EtD1, ethidium homodimer-1; FITC, fluorescein isothiocyanate; GLAST, glut...